Disposition of liposomal gentamicin following intrabronchial administration in rabbits

References

• Alexander M. R. E., Berglund E. M., Kasik J. E., Fox A., Chinn W. M. The concentration of tobramycin in bronchial secretions. Chest 1979; 75: 675–678
   PubMedGoogle Scholar
• Alexander M. R., Schoell J., Hicklin G., Kasik J. E., Coleman D. Bronchial secretion concentrations of tobramycin. American Review of Respiratory Diseases 1982; 125: 208–209
   PubMed Web of Science ®Google Scholar
• Bakker‐Woudenberg I. A.J. M., Lokerse A. F. Liposomes and lipid carriers in the treatment of microbial infections. Scandinavian Journal of Infectious Diseases 1991, Suppl. 74: 34–41
   Google Scholar
• Bakker‐Woudenberg I. A.J. M., Roerdink F. H. Antimicrobial chemotherapy directed by liposomes. Journal of Antimicrobial Chemotherapy 1986; 17: 547–549
   PubMedGoogle Scholar
• Bakker‐Woudenberg I. A.J. M., Roerdink F. H., Scherphof G. L. Drug targeting in antimicrobial chemotherapy by means of liposomes. Liposomes as Drug Carriers, Trends and Progress, G. Gregoriadis. John Wiley and Sons, Chichester 1988; 325–336
   Google Scholar
• Baran D., De Vuyst P., Ooms H. A. Concentration of tobramycin given by aerosol in the fluid obtained by bronchoalveolar lavage. Respiratory Medicine 1990; 84: 203–204
   PubMedGoogle Scholar
• Barza M., Baum J., Szoka F. Pharmacokinetics of subjonctival liposome‐encapsulated gentamicin in normal rabbit eyes. Investigative Ophthalmology and Visual Sciences 1984; 25: 486–90
   PubMed Web of Science ®Google Scholar
• Bergeron M. G. Aminosideset polypeptides. Pharmacologie. Des Concepts Fondamentaux aux Applications Thérapeutiques, M. Sorderet. Frison‐Roche Slatkine Press. 1985; 691–698
   Google Scholar
• Bergeron M. G. Tissue penetration of antibiotics. Clinical Biochemistry 1986; 19: 90–100
   PubMed Web of Science ®Google Scholar
• Bergogne‐Berezin E., Morel C., Bernard Y., Berthelot G., Kafe H. Pharmacokinetic study of β‐lactam antibiotics in bronchial secretions. Scandinavian Journal of Infectious Diseases 1978, Suppl. 14: 267–272
   Google Scholar
• Bermudez L. E. M., Wu M., Young L. S. Intracellular killing of Mycobacterium avium complex by rifapetine and liposome‐encapsulated amikacin. Journal of Infectious Diseases 1987; 148: 563–570
   Google Scholar
• Bonventre P. F., Gregoriadis G. Killing of intraphagocyte Staphylococcus aureus by dihydrostreptomycin entrapped within liposomes. Antimicrobial Agents and Chemotherapy 1978; 13: 1049–1051
   PubMed Web of Science ®Google Scholar
• Braude A. C., Chamberlain D. W., Rebuck A. S. Proportional analysis of respiratory cells observed by bronchoalveolar lavage. Canadian Medical Association Journal 1982; 126: 1401–1403
   PubMedGoogle Scholar
• Braude A. C., Hornstein A., Klein M., Vas S., Rebuck A. S. Pulmonary disposition of tobramycin. American Review of Respiratory Diseases 1983; 127: 563–565
   PubMedGoogle Scholar
• Craven D. E., Barber T. W., Steger K. A., Montecalvo M. A. Nosocomial pneumonia in the 1990s: update of epidemiology and risk factors. Seminars in Respiratory Infections 1990; 5: 157–172
   PubMedGoogle Scholar
• Debs R. J., Blumenfeld W., Brunette E. N., Straubinger R. M., Montgomery A. B., Lin E., Agabian N., Papahadjopoulos D. Successful treatment with aerosolized pentamidine of Pseudomonas carinii pneumonia in rats. Antimicrobial Agents and Chemotherapy 1987a; 31: 37–41
   PubMed Web of Science ®Google Scholar
• Debs R. J., Straubinger R. M., Brunette E. N., Lin J. M., Lin E. J., Montgomery B., Friend D. S., Papahadjopoulous D. P. Selective enhancement of pentamidine uptake in the lung by aerosolization and delivery in liposomes. American Review of Respiratory Diseases 1987b; 135: 731–737
   PubMed Web of Science ®Google Scholar
• Drusano G. L. Role of pharmacokinetics in the outcome of infections. Antimicrobial Agents and Chemotherapy 1988; 32: 289–297
   PubMed Web of Science ®Google Scholar
• Falco F. G., Smith H. M., Arcieri G. M. Nephrotoxicity of aminoglycosides and gentamicin. Journal of Infectious Diseases 1969; 119: 406–409
   PubMed Web of Science ®Google Scholar
• Farr S. J., Kellaway I. W., Parry‐Jones D. R., Woolfrey S. G. 99mTechnetium as a marker of liposomal disposition and clearance in the human lung. International Journal of Pharmaceutics 1985; 26: 303–316
   Web of Science ®Google Scholar
• Fidler I. J., Raz A., Fogler W. E., Kirsch R., Bugelski P., Poste G. Design of liposomes to improve delivery of macrophage augmenting agents to alveolar macrophages. Cancer Research 1980; 40: 4460–4466
   PubMed Web of Science ®Google Scholar
• Fielding R. M. The use of inhaled liposome formulations for drug delivery to the lungs and systemic circulation. Proceedings of West Pharmacological Society 1989; 32: 103–106
   PubMed Web of Science ®Google Scholar
• Fountain M. W., Dees C., Schultz R. D. Enhanced intracellular killing of Staphylococcus aureus by canine monocytes treated with liposomes containing amikacin, gentamicin, kanamycin and tobramycin. Current Microbiology 1981; 6: 373–376
   Google Scholar
• Fountain M. W., Weiss S. J., Fountain A. G., Shen A., Lenk R. P. Treatment of Brucella canis and Brucella abortus in vitro and in vivo by stable plurilamellar vesicle encapsulated aminoglycosides. Journal of Infectious Diseases 1985; 152: 529–535
   PubMed Web of Science ®Google Scholar
• Gangadharam P. R. J., Ashtekar D. A., Ghori N., Goldstein J. A., Debs R. J., Düzgünes N. Chemotherapeutic potential of free and liposome encapsulated streptomycin against experimental Mycobacterium avium complex infections in beige mice. Journal of Antimicrobial Chemotherapy 1991; 28: 425–435
   PubMed Web of Science ®Google Scholar
• Gilbert B. E., Six H. R., Wilson S. Z., Wyde P. R., Knight V. Small particle aerosols of enviroxime‐containing liposomes. Antiviral Research 1988; 9: 355–365
   PubMed Web of Science ®Google Scholar
• Hirano K., Hunt C. A. Lymphatic transport of liposome‐encapsulated agent: effects of liposome size following intraperitoneal administration. Journal of Pharmaceutical Sciences 1985; 74: 915–921
   PubMed Web of Science ®Google Scholar
• Juliano R. L., McCullough H. N. Controlled delivery of an antitumor drug: localized action of liposome encapsulated cytosine arabinoside administered via the respiratory system. Journal of Pharmacology and Experimental Therapeutics 1980; 214: 381–387
   PubMed Web of Science ®Google Scholar
• Kamarei A., Wong A., McCalden T. Methodology for efficacy study of liposome bronchodilators in long duration experiments. Proceedings of West Pharmacological Society 1989; 32: 33–35
   PubMedGoogle Scholar
• Klastersky J. Endotracheal therapy with aminoglycosides for gram‐negative bacillary bronchopneumonia in tracheotomized patients. Current Chemotherapy of Infectious Diseases 1980; 1: 38
   Google Scholar
• Klastersky J., Geuning C., Mouawad E., Daneau D. Endotracheal gentamicin in bronchial infections in patients with tracheotomy. Chest 1972; 61: 117–120
   PubMed Web of Science ®Google Scholar
• Klastersky J., Huysmans E., Weerts D., Hensgens C., Daneau D. Endotracheally administered gentamicin for the prevention of infections of the respiratory tract in patients with tracheostomy: a double‐blind study. Chest 1974; 65: 650–654
   PubMed Web of Science ®Google Scholar
• Klastersky J., Hensgens C., Noterman J., Mouawad E., Carpentier‐Meunier F. Endotracheal antibiotics for the prevention of tracheobronchial infection in tracheotomized unconscious patients. A comparative study of gentamicin and aminosidin‐polymyxin B combination. Chest 1975; 68: 302–306
   PubMed Web of Science ®Google Scholar
• Legros F. J., Leroy C. P. European Patent Application No. 89 911009.2, 1989, Pharmaceutical composition containing a hydrophilic active compound treated by an organic acid and encapsulated in a liposome
   Google Scholar
• Legros F., Akodad E. M., De Maeyer P., Yernault J. C., Van Vooren J. P. Liposomal encapsulation of gentamicin decreases blood levels after intratracheal administration. European Respiratory Journal 1990; 3: 281s
   Google Scholar
• Leu H. S., Kaiser D. L., Mori M., et al. Hospital‐acquired pneumonia: attributable mortality and morbidity. American Journal of Epidemiology 1989; 129: 1258–1267
   PubMed Web of Science ®Google Scholar
• Lyon M. D., Smith K. R., Saag M. S., Cloud G. A., Cobbs C. G. In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 1986; 30: 25–30
   PubMedGoogle Scholar
• McCullough H. N., Juliano R. L. Organ‐selective action of an antitumor drug. Journal of the National Cancer Institute 1979; 63: 727–731
   PubMed Web of Science ®Google Scholar
• McLeod D. L., Prescott J. F. The use of liposomally‐entrapped gentamicin in the treatment of bovine Staphylococcus aureus mastitis. Canadian Journal of Veterinary Research 1988; 52: 445–450
   PubMedGoogle Scholar
• Meisner D., Pringle J., Mezei M. Liposomal pulmonary drug delivery I. In vivo disposition of atropine base in solution and liposomal form following intra‐bronchial instillation to the rabbit lung. Journal of Microencapsulation 1989; 6: 379–387
   PubMed Web of Science ®Google Scholar
• Morgan J. R., Williams K. E. Preparation and properties of liposome‐associated gentamicin. Antimicrobial Agents and Chemotherapy 1980; 17: 544–548
   PubMed Web of Science ®Google Scholar
• Nacucchio M. C., Gatto Bellora M. J., Sordelli D. O., D'Aquino M. Enhanced liposome‐mediated antibacterial activity of piperacillin and gentamicin against gram‐negative bacilli in vitro. Journal of Microencapsulation 1988; 5: 303–309
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobicallysecond edition. NCCLS, Villanova, PA 1990; 1–31, Approved Standard. NCCLS Document M7‐A2
   Google Scholar
• Padmanabhan E. V., Gudapaty R., Liener I. E., Schwartz B. A., Hoidal J. R. Protection against pulmonary oxygen toxicity in rats by the intratracheal administration of liposome‐encapsulated superoxide dismutase or catalase. American Review of Respiratory Diseases 1985; 132: 164–167
   PubMed Web of Science ®Google Scholar
• Pettenazzo A., Jobe A., Ikegami M., Abra R., Hogue E., Mihalko P. Clearance of phosphatidylcholine and cholesterol from liposomes, liposomes loaded with metaproterenol, and rabbit surfactant from adult rabbit lungs. American Review of Respiratory Diseases 1989; 139: 752–758
   PubMed Web of Science ®Google Scholar
• Peyman G. A., Charles H. C., Liu K. ‐R., Khoobehi B., Niesman M. Intravitreal liposome‐encapsulated drugs: a preliminary human report. International Ophthalmology 1988; 12: 175–182
   PubMed Web of Science ®Google Scholar
• Schreier H., Levy M., Milhalko P. Sustained release of liposome‐encapsulated gentamicin and fate of phospholipid following intramuscular injection in mice. Journal of Controlled Release 1987; 5: 187–192
   Google Scholar
• Segal A. W., Willis E. J., Richmond J. E., Slavin G., Block C. D. V., Gregoriadis G. Morphological observations on the cellular and subcellular destinations of intravenously administered liposomes. British Journal of Experimental Pathology 1974; 55: 320–327
   PubMedGoogle Scholar
• Siegenthaler W. E., Bonetti A., Luthy R. Aminoglycoside antibiotics in infectious diseases: an overview. American Journal of Medicine 1986; 80(Suppl. 6B)2–14
   PubMedGoogle Scholar
• Smith B. R., Lefrock J. L. Bronchial tree penetration of antibiotics. Chest 1983; 83: 904–908
   PubMedGoogle Scholar
• Spencer H. The bacterial pneumonias. Pathology of the Lung, H. Spencer. Pergamon Press, Oxford 1985; 167–213
   Google Scholar
• Tadakuma T., Ikewaki N., Yasuda T., Tsutsumi M., Saito S., Saito K. Treatment of experimental salmonellosis in mice with streptomycin entrapped in liposomes. Antimicrobial Agents and Chemotherapy 1985; 28: 28–32
   PubMed Web of Science ®Google Scholar
• Vladimirsy M. A., Ladiginia G. A. Antibacterial activity of liposome‐entrapped streptomycin in mice infected with Mycobacterium tuberculosis. Biomedicine 1982; 36: 375–377
   Google Scholar
• Wersäll J., Lundquist P. ‐G., Björkroth B. Ototoxicity of gentamicin. Journal of Infectious Diseases 1969; 119: 410–416
   PubMed Web of Science ®Google Scholar
• Wise R. The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy. Clinical Pharmacokinetics 1986; 11: 470–482
   PubMed Web of Science ®Google Scholar
• Wyde P. R., Six H. R., Wilson S. Z., Gilbert B. E., Knight V. Activity against rhinoviruses, toxicity and delivery in aerosol of enviroxime in liposomes. Antimicrobial Agents and Chemotherapy 1988; 32: 890–895
   PubMed Web of Science ®Google Scholar